Neurometrix Inc news

   Watch this stock
Showing stories 1 - 10 of about 77   

Articles published

NURO 1.70 +0.01 (0.59%)
price chart
Form 4 NeuroMetrix, Inc. For: Mar 10 Filed by: SURGENOR TIMOTHY R
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). 1. Name and Address of Reporting Person *. SURGENOR TIMOTHY R. (Last), (First), (Middle). C/O NEUROMETRIX, INC. 62 FOURTH AVENUE ...
Neurometrix Inc (NURO): Is NeuroMetrix A Good Buy?
NeuroMetrix (NASDAQ:NURO) is a medical device company that develops and markets devices for the treatment and management of the neurological complications of diabetes.
Analyst Rating Update on NeuroMetrix, Inc.
Research firm Zacks has rated Neurometrix Inc (NASDAQ:NURO) and has ranked it at 3, indicating that for the short term the shares are a hold.
Kenneth J. Snow, M.D., Chief Medical Officer of NeuroMetrix, Inc. Interviewed ...
WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com, a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, reported today that its Chief Medical Officer ...
Related articles »  
NeuroMetrix to Unveil Revolutionary Wearable Pain Relief Device at 2015 ...
NeuroMetrix is an innovative health-care company that develops wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders.
Related articles »  
NeuroMetrix Skyrockets On FDA Approval For Its Wearable Device
NeuroMetrix Inc. (NURO) soared over 30% after the Food and Drug Administration (FDA) approved the company's pain relieving wearable device for over-the-counter sale in the US.
NeuroMetrix gets clearance to market an over-the-counter pain management ...  Boston Globe
With consumer product, NeuroMetrix CEO says he'll need to open a new ...  Boston Business Journal (blog)
Related articles »  
NeuroMetrix to Showcase Quell� Wearable Pain Relief Technology at the 2015 ...
WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO) will unveil and demonstrate Quell, a novel wearable pain relief device at the 2015 International Consumer Electronics show (CES) January 6-9 in Las Vegas.
Related articles »  
NeuroMetrix, Inc. (NASDAQ:NURO) Update: NeuroMetrix says exceeds ...
NeuroMetrix, Inc. (NASDAQ:NURO) Updated based on the most recent released information, NeuroMetrix says exceeds Indiegogo campaign goal for Quell in 48 hours.
NeuroMetrix Launches Indiegogo Campaign for Quell� Wearable Pain Relief ...  Yahoo Finance UK
NeuroMetrix Exceeds Indiegogo Campaign Goal for Quell� Wearable Pain ...  Business Wire (press release)
The Future Of NeuroMetrix
NeuroMetrix was once a Robin Hood story: the company stole from the neurologists, gave to the family practitioners, and made awesome margins in doing so.
Related articles »  
Sabby Management Buys 3 Biotech Stocks
Traders may want to take note of holdings disclosed by Sabby Management LLC to the SEC on Thursday. The firm reported 9.99 percent ownership stakes in the following biotech companies: Neurometrix Inc (NASDAQ: NURO) is a medical device company ...